Publication | Closed Access

Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trial

Treatment-experienced Hiv-1-infected PatientsTreatment And PreventionHuman RetrovirusImmunologyClinical Trials24-Week ResultsAntiviral Drug DevelopmentAntiviral TherapyPlacebo-controlled TrialPharmacotherapyAntiviral DrugHivImmunotherapyMedicine